Diagnostics in cardio-oncology: a focus on anthracyclines
- PMID: 41857312
- DOI: 10.1007/s10741-026-10604-8
Diagnostics in cardio-oncology: a focus on anthracyclines
Keywords: CHO; Cardio-oncology; Cardiotoxicity; Diagnostics; ECG; MRI.
Conflict of interest statement
Declarations. Ashot Avagimyan is the first author of this submission and it is a part of his Doctor of Science (DSc) in Medicine degree. Competing interests: The authors declare no competing interests.
References
-
- Imran S, Rao MS, Shah MH et al (2024) Evolving perspectives in reverse cardio-oncology: a review of current status, pathophysiological insights, and future directives. Curr Probl Cardiol 49(3):102389. https://doi.org/10.1016/j.cpcardiol.2024.102389 - DOI - PubMed
-
- Shi S, Lv J, Chai R et al (2023) Opportunities and challenges in cardio-oncology: a bibliometric analysis from 2010 to 2022. Curr Probl Cardiol 48(8):101227. https://doi.org/10.1016/j.cpcardiol.2022.101227 - DOI - PubMed
-
- Ahmed T, Marmagkiolis K, Ploch M et al (2023) The year in cardio-oncology 2022. Curr Probl Cardiol 48(1):101435. https://doi.org/10.1016/j.cpcardiol.2022.101435 - DOI - PubMed
-
- Pogosova NV, Boytsov SA, Preventive cardiology state of problem perspectives of development. Kardiologiia. 2024;64(1):4–13. https://doi.org/10.18087/cardio.2024.1.n2636
-
- Avagimyan A, Pogosova N, Kakturskiy L, et al. Doxorubicin-related cardiotoxicity: review of fundamental pathways of cardiovascular system injury. Cardiovasc Pathol. 2024;73:107683. doi: https://doi.org/10.1016/j.carpath.2024.107683
Publication types
LinkOut - more resources
Full Text Sources
